A large database study shows lower risk for major adverse cardiovascular events and end-stage kidney disease, with no increase in adverse events.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/cardiorenal-benefits-glp-1s-found-type-1-diabetes-2026a1000g8r?src=rss
Author :
Publish date : 2026-05-19 18:24:00
Copyright for syndicated content belongs to the linked Source.
